4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
GRAIL, Inc. (GRAL) operates in the Diagnostics & Research industry and is headquartered in Menlo Park, United States with about 910 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, GRAL reported $147M in revenue and ($408M) in net income.
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.
Interactive charts & full statements → Open the GRAL valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $147M | $126M | $93M | $56M |
| Gross Profit | ($63M) | ($78M) | ($96M) | ($116M) |
| Operating Income (EBIT) | ($534M) | ($768M) | ($797M) | ($742M) |
| Net Income | ($408M) | ($2.0B) | ($1.5B) | ($5.4B) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $41M | $44M | $36M | $36M | $32M | — |
| Gross Profit | ($14M) | ($11M) | ($14M) | ($18M) | ($20M) | — |
| Operating Income (EBIT) | ($136M) | ($124M) | ($125M) | ($131M) | ($154M) | — |
| Net Income | ($93M) | ($99M) | ($89M) | ($114M) | ($106M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $2.9B | $3.0B | $3.9B | $4.9B |
| Total Liabilities | $344M | $480M | $268M | $292M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GRAL viewer.
About TickerBase · Data methodology & sources